Comparison of Two Formulations of Biphasic Insulin Aspart 70
NCT01523041
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Healthy
Interventions
DRUG:
biphasic insulin aspart 70
DRUG:
biphasic insulin aspart 70
DRUG:
biphasic insulin aspart 50
Sponsor
Novo Nordisk A/S